182 related articles for article (PubMed ID: 16651602)
1. Oral direct thrombin inhibitor ximelagatran compared with warfarin for the prevention of venous thromboembolism after total knee arthroplasty.
Lotke PA; Callaghan JJ; Dorr LD; Engh GH; Hanssen AD; Healy WL; Lachiewicz PF; Lonner JH; Nelson C; Ranawat CS; Ritter MA; Salvati EA; Sculco TP; Thornhill TS
J Bone Joint Surg Am; 2006 May; 88(5):1163; author reply 1163-5. PubMed ID: 16651602
[No Abstract] [Full Text] [Related]
2. Oral direct thrombin inhibitor ximelagatran compared with warfarin for the prevention of venous thromboembolism after total knee arthroplasty.
Colwell CW; Berkowitz SD; Lieberman JR; Comp PC; Ginsberg JS; Paiement G; McElhattan J; Roth AW; Francis CW;
J Bone Joint Surg Am; 2005 Oct; 87(10):2169-77. PubMed ID: 16203879
[TBL] [Abstract][Full Text] [Related]
3. Clinical experience with ximelagatran in orthopaedic surgery.
Eriksson B
Drugs; 2004; 64 Suppl 1():27-35. PubMed ID: 15586625
[TBL] [Abstract][Full Text] [Related]
4. Ximelagatran versus warfarin for the prevention of venous thromboembolism after total knee arthroplasty. A randomized, double-blind trial.
Francis CW; Davidson BL; Berkowitz SD; Lotke PA; Ginsberg JS; Lieberman JR; Webster AK; Whipple JP; Peters GR; Colwell CW
Ann Intern Med; 2002 Oct; 137(8):648-55. PubMed ID: 12379064
[TBL] [Abstract][Full Text] [Related]
5. Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement.
Francis CW; Berkowitz SD; Comp PC; Lieberman JR; Ginsberg JS; Paiement G; Peters GR; Roth AW; McElhattan J; Colwell CW;
N Engl J Med; 2003 Oct; 349(18):1703-12. PubMed ID: 14585938
[TBL] [Abstract][Full Text] [Related]
6. Summaries for patients. Ximelagatran versus warfarin to prevent blood clots after knee replacement surgery.
Ann Intern Med; 2002 Oct; 137(8):I38. PubMed ID: 12379093
[No Abstract] [Full Text] [Related]
7. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
Colwell C; Mouret P
Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the oral direct thrombin inhibitor ximelagatran with enoxaparin as prophylaxis against venous thromboembolism after total knee replacement: a phase 2 dose-finding study.
Heit JA; Colwell CW; Francis CW; Ginsberg JS; Berkowitz SD; Whipple J; Peters G;
Arch Intern Med; 2001 Oct; 161(18):2215-21. PubMed ID: 11575978
[TBL] [Abstract][Full Text] [Related]
9. Direct thrombin inhibitor melagatran followed by oral ximelagatran in comparison with enoxaparin for prevention of venous thromboembolism after total hip or knee replacement.
Eriksson BI; Agnelli G; Cohen AT; Dahl OE; Mouret P; Rosencher N; Eskilson C; Nylander I; Frison L; Ogren M;
Thromb Haemost; 2003 Feb; 89(2):288-96. PubMed ID: 12574809
[TBL] [Abstract][Full Text] [Related]
10. Ximelagatran/Melagatran: a review of its use in the prevention of venous thromboembolism in orthopaedic surgery.
Evans HC; Perry CM; Faulds D
Drugs; 2004; 64(6):649-78. PubMed ID: 15018597
[TBL] [Abstract][Full Text] [Related]
11. A review of the oral direct thrombin inhibitor ximelagatran: not yet the end of the warfarin era..
Mohapatra R; Tran M; Gore JM; Spencer FA
Am Heart J; 2005 Jul; 150(1):19-26. PubMed ID: 16084146
[TBL] [Abstract][Full Text] [Related]
12. Prevention of venous thromboembolic disease following primary total knee arthroplasty. A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin.
Fitzgerald RH; Spiro TE; Trowbridge AA; Gardiner GA; Whitsett TL; O'Connell MB; Ohar JA; Young TR;
J Bone Joint Surg Am; 2001 Jun; 83(6):900-6. PubMed ID: 11407799
[TBL] [Abstract][Full Text] [Related]
13. Ximelagatran for treatment and prophylaxis of recurrent events in deep vein thrombosis.
Koscielny J; Kiesewetter H; Jörg I; Harenberg J
Clin Appl Thromb Hemost; 2007 Jul; 13(3):299-307. PubMed ID: 17636192
[TBL] [Abstract][Full Text] [Related]
14. Ximelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis: a randomized trial.
Fiessinger JN; Huisman MV; Davidson BL; Bounameaux H; Francis CW; Eriksson H; Lundström T; Berkowitz SD; Nyström P; Thorsén M; Ginsberg JS;
JAMA; 2005 Feb; 293(6):681-9. PubMed ID: 15701909
[TBL] [Abstract][Full Text] [Related]
15. Ximelagatran.
Choudhury A; Goyal D; Lip GY
Drugs Today (Barc); 2006 Jan; 42(1):3-19. PubMed ID: 16511607
[TBL] [Abstract][Full Text] [Related]
16. A dose-ranging study of the oral direct thrombin inhibitor, ximelagatran, and its subcutaneous form, melagatran, compared with dalteparin in the prophylaxis of thromboembolism after hip or knee replacement: METHRO I. MElagatran for THRombin inhibition in Orthopaedic surgery.
Eriksson BI; Arfwidsson AC; Frison L; Eriksson UG; Bylock A; Kälebo P; Fager G; Gustafsson D
Thromb Haemost; 2002 Feb; 87(2):231-7. PubMed ID: 11858482
[TBL] [Abstract][Full Text] [Related]
17. Treating patients with venous thromboembolism: initial strategies and long-term secondary prevention.
Huisman MV; Bounameaux H
Semin Vasc Med; 2005 Aug; 5(3):276-84. PubMed ID: 16123915
[TBL] [Abstract][Full Text] [Related]
18. Secondary prevention of venous thromboembolism with the oral direct thrombin inhibitor ximelagatran.
Schulman S; Wåhlander K; Lundström T; Clason SB; Eriksson H;
N Engl J Med; 2003 Oct; 349(18):1713-21. PubMed ID: 14585939
[TBL] [Abstract][Full Text] [Related]
19. Ximelagatran versus warfarin after total knee replacement.
Schillaci G; Pasqualini L; Mannarino E
N Engl J Med; 2004 Feb; 350(6):616-7; author reply 616-7. PubMed ID: 14768067
[No Abstract] [Full Text] [Related]
20. Ximelagatran: an orally active direct thrombin inhibitor.
Gulseth MP
Am J Health Syst Pharm; 2005 Jul; 62(14):1451-67. PubMed ID: 15998925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
